These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14175997)

  • 21. [Anti-poliomyelitis vaccination campaign and comparative evaluation of the vaccines].
    MATILLA V
    Med Trop (Madr); 1963; 39():127-49. PubMed ID: 13933670
    [No Abstract]   [Full Text] [Related]  

  • 22. Virus-polysaccharide interactions. II. Enhancement of plague formation and the detection of variants of poliovirus with dextran sulfate.
    TAKEMOTO KK; LIEBHABER H
    Virology; 1962 Jul; 17():499-501. PubMed ID: 13919219
    [No Abstract]   [Full Text] [Related]  

  • 23. Poliomyelitis in Kenya--the 1960 epidemic and oral vaccine campaign.
    FENDALL NR
    J Trop Med Hyg; 1962 Oct; 65():245-55. PubMed ID: 13962908
    [No Abstract]   [Full Text] [Related]  

  • 24. [Polio vaccines and immunological effectiveness. 1. On problems related to polio vaccines].
    OGATANI I
    Nihon Densenbyo Gakkai Zasshi; 1962 Nov; 36():382-6. PubMed ID: 13939565
    [No Abstract]   [Full Text] [Related]  

  • 25. Experience with preparation an laboratory control of oral poliomyelitis vaccine in Czechoslovakia.
    SLONIM D; MARES I; DREVO M; STURMOVA H; SIMON J
    Bull World Health Organ; 1962; 26(3):331-9. PubMed ID: 13913913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination against poliomyelitis in Petropolis].
    MARCONDES RS
    Arq Fac Hig Saude Publica Univ Sao Paulo; 1961-1962; 15-16():29-33. PubMed ID: 13932892
    [No Abstract]   [Full Text] [Related]  

  • 27. Large-scale use of Sabin type 2 attenuated poliovirus vaccine in Singapore during a type 1 poliomyelitis epidemic.
    HALE JH; DORAISINGHAM M; KANAGARATNAM K; LEONG KW; MONTEIRO ES
    Br Med J; 1959 Jun; 1(5137):1541-9. PubMed ID: 13662613
    [No Abstract]   [Full Text] [Related]  

  • 28. The PRESENT status of oral live poliovirus vaccines.
    Can Med Assoc J; 1960 Sep; 83(11):606-7. PubMed ID: 13856943
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the problem of neurologic complications following oral immunization by pollomyelitis virus type I (Sabin)].
    PETTE H
    Dtsch Med Wochenschr; 1963 Apr; 88():886 passim. PubMed ID: 13942965
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contribution to the problem of complications following peroral poliomyelitis vaccination].
    FISCHER HR; SCHAER M; PULVER W
    Ther Umsch; 1963 Mar; 20():124-8. PubMed ID: 13963019
    [No Abstract]   [Full Text] [Related]  

  • 31. [Poliomyelitis and abacterial meningitis among the present-day patients of a pediatric clinic].
    MEYFARTH G
    Arch Kinderheilkd; 1963 Jun; 168():230-47. PubMed ID: 13935352
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of poliovirus vaccine live, oral (Sabin), trivalent, in metropolitan Toronto, 1962.
    BOYD AR; MOSLEY W
    Can J Public Health; 1962 Aug; 53():326-9. PubMed ID: 13872138
    [No Abstract]   [Full Text] [Related]  

  • 33. The safety test for poliomyelitis vaccine. III. Comparative sensitivity of rhesus and vervet monkeys to poliovirus.
    VAN HOOSIER GL; BARON S; KIRSCHSTEIN RL; ABINANTI FR
    Am J Hyg; 1962 Jan; 75():86-9. PubMed ID: 13924586
    [No Abstract]   [Full Text] [Related]  

  • 34. Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
    WARREN J; HARE JD; GOLDMAN C
    Am J Public Health Nations Health; 1959 Jan; 49(1):53-61. PubMed ID: 13617534
    [No Abstract]   [Full Text] [Related]  

  • 35. Poliovirus vaccine, live, oral (Sabin). First field trial in India. I. Administration of the vaccine.
    GHARPURE PV; DAVE KH
    Indian J Med Sci; 1962 Jan; 16():1-27. PubMed ID: 13898175
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of cytopathic effect and propagation of poliovirus by methylene blue.
    KOVACS E
    Z Naturforsch B; 1960 Sep; 15B():588-92. PubMed ID: 13831052
    [No Abstract]   [Full Text] [Related]  

  • 37. [The mechanism of the effects of heavy water on the development of poliovirus].
    LWOFF A; LWOFF M
    C R Hebd Seances Acad Sci; 1961 Jan; 252():223-5. PubMed ID: 13764527
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of heavy water on the development of poliovirus as a function of temperature].
    LWOFF A; LWOFF M
    C R Hebd Seances Acad Sci; 1961 Jan; 252():223-5. PubMed ID: 13764526
    [No Abstract]   [Full Text] [Related]  

  • 39. Preparation and inactivation of purified poliovirus: comparison of vaccines derived from Mahoney and Parker poliovirus.
    CHARNEY J; FISHER WP; MACHLOWITZ RA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):601-5. PubMed ID: 13505802
    [No Abstract]   [Full Text] [Related]  

  • 40. The kinetic of induction of plaque formation in cell monolayers by ribonucleic acid from poliovirus.
    KOCH G
    Experientia; 1960 Nov; 16():490-1. PubMed ID: 13757325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.